Laval, Canada

Pierre-Andre Fournier

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Actelion Pharmaceuticals Ltd. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pierre-Andre Fournier. Retrieved from https://idiyas.com/inventor/pierre-andre-fournier-crs8v8s3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pierre-Andre Fournier: Innovator in Renin Inhibitor Compounds

Introduction

Pierre-Andre Fournier is a notable inventor based in Laval, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as renin inhibitors. His work is crucial in addressing cardiovascular events and renal insufficiency.

Latest Patents

Fournier holds a patent for "3,4-substituted piperidine derivatives as renin inhibitors." This invention relates to compounds that are based on 3,4-substituted piperidinyl structures, specifically those bearing oxopyridine at the 4-position. The patent outlines the formula (I) for these compounds and discusses their pharmaceutical compositions and applications in treating various health conditions.

Career Highlights

Pierre-Andre Fournier is associated with Actelion Pharmaceuticals Ltd., where he has been instrumental in advancing research and development in the pharmaceutical sector. His expertise in creating innovative compounds has positioned him as a valuable asset to the company.

Collaborations

Fournier has collaborated with several talented individuals in his field, including Austin Chih-Yu Chen and Daniel Dube. These collaborations have likely contributed to the success of his projects and the advancement of their shared goals in pharmaceutical innovation.

Conclusion

Pierre-Andre Fournier's work in developing renin inhibitors showcases his commitment to improving healthcare through innovation. His contributions are vital in the ongoing efforts to treat cardiovascular and renal conditions effectively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…